Get the Stockscreener App
8.43
17.74%
1.27
After Hours:
8.53
0.10
+1.19%
Verrica Pharmaceuticals Inc Stock (VRCA) Forecast
The Verrica Pharmaceuticals Inc (VRCA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $12.67, representing a +50.30% increase from the current price of $8.43. The highest analyst price target is $14.92, and the lowest is $10.42.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VRCA Price Target
Average 10.01
(+18.78% Upside)
Is Verrica Pharmaceuticals Inc (VRCA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 75.38 | Sell |
| STOCH(9,6) | 44.81 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.406 | Buy |
| ADX(14) | 24.13 | Neutral |
| William %R | -2.9787 | Sell |
| CCI(14) | 167.82 | Buy |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.7995
Buy
|
6.882
Buy
|
| MA20 |
6.396
Buy
|
6.5124
Buy
|
| MA50 |
5.8346
Buy
|
6.2001
Buy
|
| MA100 |
6.609
Buy
|
6.1601
Buy
|
| MA200 |
5.8865
Buy
|
6.124
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, VRCA could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 3 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on VRCA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 75.38 indicates that VRCA is overbought. This suggests that VRCA price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 44.81 indicates that VRCA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that VRCA is oversold. This suggests that VRCA price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.13 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 167.82 indicates that VRCA is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term VRCA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Verrica Pharmaceuticals Inc financial reports and earnings history, Verrica Pharmaceuticals Inc (VRCA) stock could reach $5.5697 by 2030, $1.381 by 2040 and $1.6277 by 2050. See the projected annual prices until 2050 of the Verrica Pharmaceuticals Inc stock below:
- Verrica Pharmaceuticals Inc (VRCA) is expected to reach an average price of $0.2262 in 2035, with a high prediction of $0.5444 and a low estimate of $0.0256. This indicates an $-97.32% rise from the last recorded price of $8.43.
- Verrica Pharmaceuticals Inc (VRCA) stock is projected to chart a bullish course in 2040, with an average price target of $0.6387, representing an $-92.42% surge from its current level. The forecast ranges from a conservative $0.1087 to a sky-high $1.381.
- Our analysts predict Verrica Pharmaceuticals Inc (VRCA) to jump -38.26% by 2045, soaring from $4.0883 to an average price of $5.2047, potentially reaching $4.4426. While $4.0883 is the low estimate, the potential upside is significant.
- Verrica Pharmaceuticals Inc (VRCA) stock is expected to climb by 2050, reaching an average of $1.2578, a $-85.08% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1.6277 and $1.9973, respectively, highlighting the market's uncertainty.
Verrica Pharmaceuticals Inc Stock (VRCA) Year by Year Forecast
Verrica Pharmaceuticals Inc Stock (VRCA) Price Forecast for 2026
The predicted value for Verrica Pharmaceuticals Inc (VRCA) in 2026 is set at an average of $9.2267. Estimates vary from a peak of $16.33 to a trough of $2.125, indicating an +9.45% surge from the present price of $8.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2026 | $11.68 | $10.42 | $14.92 | +38.53% |
| July, 2026 | $9.6281 | $8.8831 | $12.27 | +14.21% |
| August, 2026 | $8.426 | $7.534 | $10.03 | -0.05% |
| September, 2026 | $8.3158 | $8.0158 | $10.55 | -1.35% |
| October, 2026 | $8.5737 | $7.9497 | $9.8197 | +1.70% |
| November, 2026 | $9.1615 | $7.2076 | $9.8615 | +8.68% |
| December, 2026 | $10.48 | $7.1894 | $12.75 | +24.33% |
Verrica Pharmaceuticals Inc Stock (VRCA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Verrica Pharmaceuticals Inc (VRCA) is $5.8196, with a high forecast of $11.62 and a low forecast of $0.0218. This indicates an -30.97% decrease from the last price of $8.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $10.77 | $9.8053 | $11.62 | +27.75% |
| February, 2027 | $9.4271 | $8.4671 | $11.52 | +11.83% |
| March, 2027 | $7.0969 | $6.501 | $10.06 | -15.81% |
| April, 2027 | $6.3248 | $6.1598 | $7.9509 | -24.97% |
| May, 2027 | $5.8327 | $5.1087 | $6.6268 | -30.81% |
| June, 2027 | $6.1625 | $5.6356 | $6.8525 | -26.90% |
| July, 2027 | $6.1404 | $5.4745 | $6.8384 | -27.16% |
| August, 2027 | $5.3382 | $5.2182 | $7.2543 | -36.68% |
| September, 2027 | $0.0481 | $0.1519 | $5.4401 | -99.43% |
| October, 2027 | $0.3059 | $0.034 | $0.574 | -96.37% |
| November, 2027 | $1.5138 | $0.0218 | $1.6838 | -82.04% |
| December, 2027 | $2.1136 | $0.9758 | $2.1736 | -74.93% |
Verrica Pharmaceuticals Inc Stock (VRCA) Price Forecast for 2028
In 2028, Verrica Pharmaceuticals Inc (VRCA) is projected to reach an average price of $3.4773, with a high projection of $6.8316 and a low estimate of $0.1231. This indicates an -58.75% fall from the last price of $8.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.0215 | $1.2656 | $2.2055 | -76.02% |
| February, 2028 | $1.0094 | $0.6874 | $2.5505 | -88.03% |
| March, 2028 | $0.5892 | $0.3972 | $1.3113 | -93.01% |
| April, 2028 | $0.6971 | $0.1231 | $1.0464 | -91.73% |
| May, 2028 | $0.6269 | $0.5469 | $1.613 | -92.56% |
| June, 2028 | $2.2748 | $0.4489 | $3.1728 | -73.02% |
| July, 2028 | $5.2326 | $2.2567 | $5.4977 | -37.93% |
| August, 2028 | $4.7025 | $4.4914 | $6.8316 | -44.22% |
| September, 2028 | $4.1903 | $4.0751 | $5.4044 | -50.29% |
| October, 2028 | $4.7082 | $3.7962 | $4.8743 | -44.15% |
| November, 2028 | $3.878 | $3.4161 | $5.1901 | -54.00% |
| December, 2028 | $3.9459 | $3.4759 | $4.692 | -53.19% |
Verrica Pharmaceuticals Inc Stock (VRCA) Price Forecast for 2029
The 2029 price forecast for Verrica Pharmaceuticals Inc Stock (VRCA) is $3.5089 on average, with a high prediction of $5.9368 and a low estimate of $1.0811. This represents an -58.38% decrease from the previous price of $8.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.0257 | $2.9338 | $5.9368 | -52.25% |
| February, 2029 | $2.6836 | $2.4236 | $4.0077 | -68.17% |
| March, 2029 | $2.2514 | $2.1914 | $3.0075 | -73.29% |
| April, 2029 | $1.8593 | $1.7893 | $2.3634 | -77.94% |
| May, 2029 | $1.2941 | $1.2291 | $2.3272 | -84.65% |
| June, 2029 | $2.047 | $1.0811 | $2.175 | -75.72% |
| July, 2029 | $5.5549 | $1.7609 | $5.7449 | -34.11% |
| August, 2029 | $3.8947 | $3.6153 | $5.5235 | -53.80% |
| September, 2029 | $3.4326 | $3.0126 | $4.0667 | -59.28% |
| October, 2029 | $3.2724 | $2.8624 | $4.3045 | -61.18% |
| November, 2029 | $5.2503 | $3.0444 | $5.5883 | -37.72% |
| December, 2029 | $4.55 | $3.96 | $5.8542 | -46.03% |
Verrica Pharmaceuticals Inc Stock (VRCA) Price Forecast for 2030
Verrica Pharmaceuticals Inc Stock (VRCA) is expected to reach an average price of $8.2308 in 2030, with a high forecast of $14.20 and a low forecast of $2.2657. This signifies an -2.36% decrease from the last price of $8.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.8497 | $2.2657 | $5.5697 | -42.47% |
| February, 2030 | $6.4554 | $4.2727 | $7.9315 | -23.42% |
| March, 2030 | $5.9311 | $5.4443 | $7.8811 | -29.64% |
| April, 2030 | $5.1969 | $3.8529 | $6.9851 | -38.35% |
| May, 2030 | $10.01 | $4.6108 | $11.21 | +18.76% |
| June, 2030 | $10.15 | $8.7023 | $11.40 | +20.43% |
| July, 2030 | $10.38 | $8.4006 | $11.23 | +23.15% |
| August, 2030 | $11.13 | $8.1337 | $14.20 | +32.00% |
| September, 2030 | $10.67 | $9.6934 | $12.70 | +26.61% |
| October, 2030 | $10.65 | $9.5952 | $13.09 | +26.37% |
| November, 2030 | $4.1788 | $2.8088 | $10.78 | -50.43% |
| December, 2030 | $5.7495 | $2.4927 | $7.5766 | -31.80% |
1.77%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):